Mammoth Biosciences

Mammoth Biosciences is a biotech company that has developed the world’s first and only CRISPR-based detection platform capable of sensing any biomarker or disease with DNA/RNA. CRISPR pioneer Jennifer Doudna and Trevor Martin, Ashley Tehranchi, Janice Chen and Lucas Harrington co-founded the company. Mammoth is on a mission to leverage the power of CRISPR to democratize disease detection by bringing accurate and affordable testing out of the laboratory and into the point of care. The company has raised nearly $25 million in funding from investors including Mayfield, NFX, 8VC, AME Cloud, Wireframe, Kairos and Boom Capital.

Visite el sitio web de Mammoth Biosciences

Mammoth Biosciences colaboradores

Suscribirse a las actualizaciones

Una actualización semanal de lo que hay en la Agenda Global

© 2021 World Economic Forum

Política de privacidad y normas de uso